FISH;
acute lymphoblastic leukaemia;
Philadelphia chromosome;
BCR-ABL gene;
D O I:
10.1111/j.1445-5994.1999.tb01619.x
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Philadelphia positive (Ph+) acute lymphoblastic leukaemia (ALL) accounts for 11-29% of adult ALL. Reverse transcriptase polymerase chain reaction (RT-PCR) for the BCR-ABL fusion mRNA has identified patients with the fusion mRNA without cytogenetic evidence of the 9;22 translocation. The reason for discrepancies between cytogenetic and molecular diagnoses is unclear. Aim: Our aim was to study cases of ALL with discordant cytogenetic and RT-PCR results and identify any reasons for such discrepancies. Methods: Laboratory records were scanned for cases of ALL tested by both RT-PCR and cytogenetics and positive by either for the 9;22 translocation. Fluorescence in situ hybridisation (FISH) was used to study discordant results where a specimen was available. Results: We identified 15 patients with ALL who had both cytogenetic and RT-PCR studies for BCR-ABL. Seven had discordant results; five patients had positive RT-PCR studies with normal (four/five) or abnormal but Ph negative cytogenetics (one/five), and two were Ph+ but RT-PCR negative. FISH, using Vysis LSI bcr/abl translocation probes, showed fused signals in 12% interphase cells but not in metaphase cells in one specimen with normal cytogenetics, and 6% interphase cells in the Ph negative patient with abnormal cytogenetics. This second patient subsequently relapsed with a minor Ph+ cell line derived from the Ph negative line. Conclusions: These results confirmed the need for both cytogenetics and RT-PCR to identify Ph+ ALL. FISH did not show sub-microscopic rearrangements of BCR-ABL in normal metaphases. Failure to identify the Philadelphia chromosome cytogenetically appeared due rather to Ph+ cells failing to divide.
机构:
Univ Washington, Dept Hematol & Oncol, Seattle, WA USA
Fred Hutchinson Canc Ctr, Seattle, WA USA
Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Dekker, Simone E.
论文数: 引用数:
h-index:
机构:
Sabile, Jean
Dasilva, Brandon
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Palo Alto, CA USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Dasilva, Brandon
论文数: 引用数:
h-index:
机构:
Saygin, Caner
Schwartz, Marc
论文数: 0引用数: 0
h-index: 0
机构:
Univ Colorado, Sch Med, Div Hematol, Aurora, CO USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Schwartz, Marc
Raman, Hari S.
论文数: 0引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Boston, MA USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Raman, Hari S.
Kaempf, Andy
论文数: 0引用数: 0
h-index: 0
机构:
Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Kaempf, Andy
Luskin, Marlise R.
论文数: 0引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Boston, MA USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Luskin, Marlise R.
Patel, Anand Ashwin
论文数: 0引用数: 0
h-index: 0
机构:
Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Patel, Anand Ashwin
Muffly, Lori S.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Palo Alto, CA USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA
Muffly, Lori S.
Leonard, Jessica T.
论文数: 0引用数: 0
h-index: 0
机构:
Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR USAUniv Washington, Dept Hematol & Oncol, Seattle, WA USA